Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating paclitaxel albumin-stabilized nanoparticle formulation (nab-paclitaxel) for metastatic intraocular melanoma that cannot be sur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Melanoma

Drugs mentioned

• Paclitaxel Albumin-Stabilized Nanoparticle Formulation (paclitaxel)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Intraocular Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2016-02-12